Correlation Between Homology Medicines and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both Homology Medicines and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Homology Medicines and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Homology Medicines and Nuvectis Pharma, you can compare the effects of market volatilities on Homology Medicines and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Homology Medicines with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Homology Medicines and Nuvectis Pharma.
Diversification Opportunities for Homology Medicines and Nuvectis Pharma
-0.18 | Correlation Coefficient |
Good diversification
The 3 months correlation between Homology and Nuvectis is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Homology Medicines and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Homology Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Homology Medicines are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Homology Medicines i.e., Homology Medicines and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between Homology Medicines and Nuvectis Pharma
If you would invest 616.00 in Nuvectis Pharma on September 5, 2024 and sell it today you would lose (119.00) from holding Nuvectis Pharma or give up 19.32% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 1.59% |
Values | Daily Returns |
Homology Medicines vs. Nuvectis Pharma
Performance |
Timeline |
Homology Medicines |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Nuvectis Pharma |
Homology Medicines and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Homology Medicines and Nuvectis Pharma
The main advantage of trading using opposite Homology Medicines and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Homology Medicines position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.Homology Medicines vs. Passage Bio | Homology Medicines vs. Stoke Therapeutics | Homology Medicines vs. Adaptimmune Therapeutics Plc | Homology Medicines vs. Black Diamond Therapeutics |
Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |